The core of the policy is that FDA will not require employees who are concerned about Zika exposure to travel to these areas. Employees may opt in or out after having consulted with FDA Occupational Health Services or their own health care provider. The policy contains a consultation form for the Centers/Offices to include in their employees’ travel records.
The subject policy covers employee travel. The Agency is developing additional guidance for:
- FDA staff residing in Zika exposure areas
- Providing prevention materials to FDA travelers
- Clarifying the authorities that would allow FDA travelers to be reimbursed for their own purchases of approved Zika prevention materials
The Zika travel policy is available in the agency’s Intranet only.